Takeda Pharmaceutical (TAK) Net Shares Issued and Repurchased (2018 - 2019)

Takeda Pharmaceutical's (TAK) quarterly Net Shares Issued and Repurchased came in at -$34.7 million in Q3 2019, down 77168.18% year-on-year from N/an in Q3 2018, and down 127004.86% quarter-over-quarter from -$27282.3 in Q2 2019.

Takeda Pharmaceutical (TAK) Net Shares Issued and Repurchased (2018 - 2019) Analysis & Trends

Takeda Pharmaceutical's Net Shares Issued and Repurchased history runs 2 years deep, the most recent figure standing at -$34.7 million for Q3 2019.

  • On a quarterly basis, Net Shares Issued and Repurchased fell 77168.18% year-over-year to -$34.7 million in Q3 2019; TTM through Sep 2019 was -$34.8 million, a N/A change from a year earlier, with the FY2019 full-year figure at -$10.6 million, changed N/A from the prior year.
  • Net Shares Issued and Repurchased fell to -$34.7 million in Q3 2019 per TAK's latest filing, from -$27282.3 in the prior quarter.
  • Across five years, Net Shares Issued and Repurchased topped out at -$27282.3 in Q2 2019 and bottomed at -$34.7 million in Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2019 -34.68 Mn
Sep 30, 2019 -34.68 Mn
Jun 30, 2019 -27,282.26
Jun 30, 2019 -27,282.26
Mar 31, 2019 -72,666.56
Mar 31, 2019 -72,666.56
Dec 31, 2018 -53,195.96
Dec 31, 2018 -53,195.96
Sep 30, 2018 -44,878.86
Sep 30, 2018 -44,878.86
Jun 30, 2018 -10.58 Mn
Jun 30, 2018 -10.58 Mn